In recent years, the U.S. Senate has investigated and exposed extensive financial conflicts of interest of prominent psychiatrists with the pharmaceutical industry amounting to millions of dollars.  Various psychiatrists who advocated the use of particular psychiatric drugs were found to be getting kickbacks from the manufacturer of those drugs. These financial conflicts of interest between psychiatrists and the pharmaceutical industry turns out to be a key part of a massive marketing scheme by pharma started many years ago to sell more expensive psychiatric drugs. Called the Texas Medication Algorithm Project, or TMAP, this national mental health screening/ psychotropic drug treatment plan has spread throughout the country and has involved government officials as well as some of the more prominent psychiatrists in the U.S. Allen Jones, who worked as an investigator in the Pennsylvania Office of the Inspector General (OIG), gained widespread national and international attention as the whistleblower who uncovered and exposed TMAP, discusses the results of these psychiatric/pharmaceutical conflicts of interest in this 32-minute show.